Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How does Spotify Wrapped calculate your listening age? What your number says about you. - 2The race to mine the moon is on – and it urgently needs some clear international rules
- 3Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- 4The architect of Iran’s military survival remains defiant
- 5Share your pick for the riding area that characterizes your surf undertakings!
- ‘Wu-Tang Forever: The Final Chamber’ tour — How to get tickets, presale times, concert dates and more
- France will build a new aircraft carrier as it increases defense spending
- Why some African countries are prone to military takeovers
- Meet the astronauts about to make history on flight around the moon
- Over 60 local leaders push Netanyahu to halt haredi draft bill, warn of social rift
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- Who is Artemis? Meet the Greek goddess who inspired NASA's return to the moon
- More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know.
